Second International Summit on Human Genome Editing
Since the first international summit was held in 2015 in Washington, D.C., research on human genome editing has continued to advance rapidly. However, many questions remain about the science, application, ethics, and governance of human genome editing. Of particular concern is the possibility of heritable genome editing, which would alter the human germline, and applications for purposes other than to treat disease or disability.
The Second International Summit on Human Genome Editing continued to advance the global dialogue on these issues by bringing together a broad range of stakeholders — including researchers, ethicists, policymakers, patient groups, and representatives from science and medical academies and organizations worldwide — to explore topics including: 1) potential benefits and risks inherent in conducting genome editing research and in considering clinical applications; 2) ethical and cultural perspectives; 3) legal, regulatory, and policy considerations; and 4) public outreach and engagement.
News From the Summit
Concluding Statement Issued
HONG KONG, Nov. 29, 2018 -- The organizing committee issued a statement at the conclusion of the summit. Read More | Statement by the Presidents
Human Genome Editing Summit Kicks Off
HONG KONG, Nov. 26, 2018 -- On the eve of the Second International Summit on Human Genome Editing, we were informed of the birth of twins in China whose embryonic genomes had been edited. The researcher who led the work, He Jiankui, is scheduled to speak at the summit on Wednesday. Read More
A message from David Baltimore, Nobel laureate and chair of the organizing committee.
Learn more about the summit in this short video.